CoaChrom^®
Kallikrein Inhibitor

Description

This kit is designed for the determination of inhibitors of plasma kallikrein in human plasma. Plasma kallikrein is added to diluted plasma and during an incubation period it complexes with plasma inhibitors. The residual plasma kallikrein activity is measured by its ability to cleave a chromogenic peptide substrate and liberate p‐nitroaniline (pNA). The concentration of pNA is measured photometrically, and is inversely proportional to the plasma inhibition of kallikrein.

Intended use

Determination of inhibitors of plasma kallikrein in human plasma. For research use only.